I don’t think we should focus too much on Qbrexza and what it does, it’s a flop. Remember triangle research said customers they surveyed would pay almost anything to get rid of their hyperhidrosis, and SB will be targeting a much broader market, with dermatologists surveyed saying they may prescribe the drug as a first line treatment, this would replace Drysol that currently does 400k prescriptions. Drysol however is much cheaper being older.
Bot Chart, page-7370
-
- There are more pages in this discussion • 8,522 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
-0.005(1.47%) |
Mkt cap ! $608.8M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.3¢ | 32.5¢ | $1.200M | 3.588M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 349093 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 25403 | 5 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |